Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes

Dynamic Changes in Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 Levels During Wound Healing in Diabetic Rats

(2014) Chuan Yang et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: Influence of insulin resistance and oxidative stress

(2011) Gabriella Doronzo et al.   ATHEROSCLEROSIS

Advanced Glycation End Product-Mediated Matrix Metallo-proteinase-9 and Apoptosis via Renin-Angiotensin System in Type 2 Diabetes

(2011) Toshiyuki Ishibashi et al.   Journal of Atherosclerosis and Thrombosis

Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications

(2010) W. Bao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA

(2010) Ping Zhu et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Mechanistic study of endogenous skin lesions in diabetic rats

(2010) Xiang-fang Chen et al.   EXPERIMENTAL DERMATOLOGY

Platelet lysate modulates MMP-2 and MMP-9 expression, matrix deposition and cell-to-matrix adhesion in keratinocytes and fibroblasts

(2010) Elia Ranzato et al.   EXPERIMENTAL DERMATOLOGY

The Novel Function of Advanced Glycation End Products in Regulation of MMP-9 Production

(2010) Fan Zhang et al.   JOURNAL OF SURGICAL RESEARCH

AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways

(2009) YaYang Liu et al.   ATHEROSCLEROSIS

Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-κB in human epidermal keratinocytes

(2009) Youngae Lee et al.   EXPERIMENTAL DERMATOLOGY

AGE-Modified Collagens I and III Induce Keratinocyte Terminal Differentiation through AGE Receptor CD36: Epidermal–Dermal Interaction in Acquired Perforating Dermatosis

(2009) Eita Fujimoto et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

(2009) Takahisa Tanikawa et al.   JOURNAL OF VASCULAR RESEARCH

Matrix metalloproteinase-9 delays wound healing in a murine wound model

(2009) Matthew J. Reiss et al.   SURGERY

3-Deoxyglucosone-collagen alters human dermal fibroblast migration and adhesion: Implications for impaired wound healing in patients with diabetes

(2009) Danielle T. Loughlin et al.   WOUND REPAIR AND REGENERATION

Advanced glycoxidation products and impaired diabetic wound healing

(2009) Melpomeni Peppa et al.   WOUND REPAIR AND REGENERATION

The RAGE Pathway

(2008) Ivan K. Lukic et al.   Annals of the New York Academy of Sciences

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

(2008) Chengbo Sun et al.   BASIC RESEARCH IN CARDIOLOGY

Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts

(2008) J. Molinari et al.   BIOGERONTOLOGY

Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer

(2008) E.A. Rayment et al.   BRITISH JOURNAL OF DERMATOLOGY

Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers

(2008) Y. Liu et al.   DIABETES CARE

The Role of Advanced Glycation End Products in Progression and Complications of Diabetes

(2008) Su-Yen Goh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

UVB and Proinflammatory Cytokines Synergistically Activate TNF-α Production in Keratinocytes through Enhanced Gene Transcription

(2008) Muhammad M. Bashir et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Metalloproteinases and their inhibitors: Regulators of wound healing

(2007) S GILL et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression

(2007) Sho-ichi Yamagishi et al.   MICROVASCULAR RESEARCH